CLINICAL ROLE -
January 24th 2025
Biosimilar use is not linked to an increased risk of treatment failure among pediatric patients with inflammatory bowel disease (IBD).
January 17th 2025
Admissions to the hospital for fever were reduced in pediatric patients with medium-risk ALL receiving intravenous immunoglobulin, a potentially useful finding to help prevent infections in vulnerable patients.
January 9th 2025
These new regulatory developments put CUTX-101 on track to become the first FDA-approved treatment for patients with Menkes disease.
January 8th 2025
This association was also observed in siblings of children with autism spectrum disorder.
January 7th 2025
Management of acute otitis media in children involves evidence-based antibiotic prescribing.
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
Web Resources for Pharmacists
Read More
Parents Still Fear Routine Child Vaccines
Persistent worries about the safety of childhood vaccines could undercut national immununization efforts, a new survey finds.
Exploring a Prescription Option for the Treatment of Head Lice
When facing a head lice infestation, patients should be aware of a new pharmacologic treatment option.
Does a Pharmacist's Legal Duty Extend to Third Parties?
A patient who abused controlled substances causes a deadly accident, and the victim's family sues the dispensing pharmacies.
Infants at Risk for Opioid Dosing Errors
Pharmacists must be vigilant against dosing errors when filling painkiller prescriptions for very young children.
The Facts of Lice
Dr. Brown is an assistant professor of pharmacy practice at Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy,West Palm Beach, Fla.